Skip to main content
. 2019 Dec 23;9(12):e032795. doi: 10.1136/bmjopen-2019-032795

Table 3.

Change scores for the IPSS and OAB-q SF by PGI-I outcomes: subgroup analysis for GP prescriptions

PGI-I outcome N (%) IPSS Missing OAB-q SF Missing
Very much better 4 (3.1) 18.0 (1.7 to 34.3) 1 30.8 (−0.9 to 62.4) 0
Much better 39 (30.2) 9.2 (7.0 to 11.5) 2 19.9 (14.8 to 24.9) 2
A little better 57 (44.2) 5.4 (4.0 to 6.7) 3 11.2 (7.0 to 15.4) 3
No change 27 (20.9) 3.1 (0.5 to 5.6) 0 3.3 (−3.4 to 9.9) 3
A little worse 2 (1.6) −8.5 (−11.6.5 to 99.5) 0 −16.5 (−353.2 to 320.2) 0

Change in IPSS and OAB-q SF scores were estimated by comparing symptom scores between baseline and 6 weeks. Mean change and 95% CIs are presented. Outcomes are inverted so that positive changes reflect symptom improvement. The PGI-I category ‘a little better’ reflects the MID for both questionnaires. None of the participants scored ‘much worsened’ or ‘very much worsened’ on the PGI-I.

IPSS, International Prostate Symptom Score; MID, minimal important difference; OAB-q SF, Overactive Bladder Questionnaire short form; PGI-I, Patient Global Impression of Improvement.